anticancer agents (University of North Carolina)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameanticancer agents (University of North Carolina)

Drug Alias Nameanticancer agents (University of North Carolina/China Medical College/NCI)antimitotics (University of North Carolina/China Medical College/NCI)quinazolinone derivatives (University of North Carolina/China Medical College/NCI)thiophene derivatives (University of North Carolina/China Medical College/NCI)tubulin polymerization inhibitors (University of North Carolina/China Medical College/NCI) +[7]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTubulin inhibitors

TargetsTubulin

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of North Carolina, Greensboro

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of North Carolina, Greensboro

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A